PMID- 36466809 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20221206 IS - 1662-5099 (Print) IS - 1662-5099 (Electronic) IS - 1662-5099 (Linking) VI - 15 DP - 2022 TI - The kappa-opioid receptor-induced autophagy is implicated in stress-driven synaptic alterations. PG - 1039135 LID - 10.3389/fnmol.2022.1039135 [doi] LID - 1039135 AB - Recent evidence has shown that G protein-coupled receptors (GPCRs) are direct sensors of the autophagic machinery and opioid receptors regulate neuronal plasticity and neurotransmission with an as yet unclarified mechanism. Using in vitro and in vivo experimental approaches, this study aims to clarify the potential role of autophagy and kappa-opioid receptor (kappa-OR) signaling in synaptic alterations. We hereby demonstrate that the selective kappa-OR agonist U50,488H, induces autophagy in a time-and dose-dependent manner in Neuro-2A cells stably expressing the human kappa-OR by upregulating microtubule-associated protein Light Chain 3-II (LC3-II), Beclin 1 and Autophagy Related Gene 5 (ATG5). Pretreatment of neuronal cells with pertussis toxin blocked the above kappa-OR-mediated cellular responses. Our molecular analysis also revealed a kappa-OR-driven upregulation of becn1 gene through ERK1,2-dependent activation of the transcription factor CREB in Neuro-2A cells. Moreover, our studies demonstrated that sub-chronic U50,488H administration in mice causes profound increases of specific autophagic markers in the hippocampus with a concomitant decrease of several pre-and post-synaptic proteins, such as spinophilin, postsynaptic density protein 95 (PSD-95) and synaptosomal associated protein 25 (SNAP25). Finally, using acute stress, a stimulus known to increase the levels of the endogenous kappa-OR ligand dynorphin, we are demonstrating that administration of the kappa-OmicronR selective antagonist, nor-binaltorphimine (norBNI), blocks the induction of autophagy and the stress-evoked reduction of synaptic proteins in the hippocampus. These findings provide novel insights about the essential role of autophagic machinery into the mechanisms through which kappa-OR signaling regulates brain plasticity. CI - Copyright (c) 2022 Karoussiotis, Sotiriou, Polissidis, Symeonof, Papavranoussi-Daponte, Nikoletopoulou and Georgoussi. FAU - Karoussiotis, Christos AU - Karoussiotis C AD - Laboratory of Cellular Signaling and Molecular Pharmacology, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece. FAU - Sotiriou, Aggeliki AU - Sotiriou A AD - Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology-Hellas, Heraklion, Crete, Greece. FAU - Polissidis, Alexia AU - Polissidis A AD - Center for Clinical Research, Experimental Surgery, and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece. FAU - Symeonof, Alexandra AU - Symeonof A AD - Laboratory of Cellular Signaling and Molecular Pharmacology, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece. FAU - Papavranoussi-Daponte, Danae AU - Papavranoussi-Daponte D AD - Laboratory of Cellular Signaling and Molecular Pharmacology, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece. FAU - Nikoletopoulou, Vassiliki AU - Nikoletopoulou V AD - Departement des Neurosciences Fondamentales, University of Lausanne, Lausanne, Switzerland. FAU - Georgoussi, Zafiroula AU - Georgoussi Z AD - Laboratory of Cellular Signaling and Molecular Pharmacology, Institute of Biosciences and Applications, National Centre for Scientific Research "Demokritos", Athens, Greece. LA - eng PT - Journal Article DEP - 20221116 PL - Switzerland TA - Front Mol Neurosci JT - Frontiers in molecular neuroscience JID - 101477914 PMC - PMC9709411 OTO - NOTNLM OT - Beclin 1 OT - CREB OT - ERK1,2 OT - Gi/o OT - autophagy OT - dynorphin OT - synaptic alterations OT - kappa-opioid receptor COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/12/06 06:00 MHDA- 2022/12/06 06:01 PMCR- 2022/01/01 CRDT- 2022/12/05 04:11 PHST- 2022/09/07 00:00 [received] PHST- 2022/10/26 00:00 [accepted] PHST- 2022/12/05 04:11 [entrez] PHST- 2022/12/06 06:00 [pubmed] PHST- 2022/12/06 06:01 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fnmol.2022.1039135 [doi] PST - epublish SO - Front Mol Neurosci. 2022 Nov 16;15:1039135. doi: 10.3389/fnmol.2022.1039135. eCollection 2022.